Profusa, Inc.

Profusa, Inc. (ticker: PFSA) is a medical technology company focused on implantable biosensor platforms designed for continuous, real-time monitoring of biochemical markers in human tissue. The company operates in the digital health and medical device sector, with its core technology targeting applications in metabolic monitoring and early disease detection. Profusa filed a Form 10-Q with the SEC on November 15, 2024, under accession number 0001213900-24-098671, reflecting its status as a publicly reporting company. Sponsor details are not confirmed in available public filings. For full filing history, deal structure, and institutional data on PFSA, sign up for a SpacDesk account at spacdesk.com.